Taking the Helm of Europe s SIMAP Consortium, Compugen Aims to Build Kinetic Modeling Skills | GenomeWeb

This article has been updated to correct a typographical error in the 14th paragraph.

Compugen this week announced that it will lead a consortium funded by the European Commission to develop a computational model of the MAP-kinase pathway.

The three-year, €3.1 million ($3.7 million) project, called SIMAP (Simulation Modeling of the MAP-kinase Pathway), marks Compugen's first involvement in biological simulation.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.